- Report
- December 2023
- 166 Pages
Global
From €2042EUR$2,350USD£1,778GBP
- Report
- September 2023
- 141 Pages
Global
From €1955EUR$2,250USD£1,702GBP
- Report
- September 2024
- 210 Pages
Global
From €1356EUR$1,560USD£1,180GBP
€2086EUR$2,400USD£1,815GBP
- Report
- August 2024
- 195 Pages
Global
From €1356EUR$1,560USD£1,180GBP
€2086EUR$2,400USD£1,815GBP
- Report
- November 2023
- 1800 Pages
Global
From €2881EUR$3,315USD£2,507GBP
€4432EUR$5,100USD£3,858GBP
- Drug Pipelines
- August 2023
- 400 Pages
China
From €1695EUR$1,950USD£1,475GBP
€2607EUR$3,000USD£2,269GBP
- Drug Pipelines
- August 2023
- 580 Pages
United States
From €2373EUR$2,730USD£2,065GBP
€3650EUR$4,200USD£3,177GBP
- Report
- May 2023
- 1500 Pages
China
From €2881EUR$3,315USD£2,507GBP
€4432EUR$5,100USD£3,858GBP
- Report
- May 2022
- 510 Pages
Global
From €1695EUR$1,950USD£1,475GBP
€2607EUR$3,000USD£2,269GBP
- Report
- October 2023
- 470 Pages
Global
From €1582EUR$1,820USD£1,377GBP
€2433EUR$2,800USD£2,118GBP
- Report
- February 2022
- 360 Pages
United States
From €2034EUR$2,340USD£1,770GBP
€3129EUR$3,600USD£2,723GBP
- Report
- February 2025
- 225 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- August 2024
- 294 Pages
Global
From €3628EUR$4,175USD£3,158GBP
- Report
- November 2024
- 207 Pages
Global
From €4041EUR$4,650USD£3,517GBP
- Report
- January 2024
- 485 Pages
Global
From €4041EUR$4,650USD£3,517GBP
- Report
- March 2023
- 185 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- February 2023
- 123 Pages
Global
From €2173EUR$2,500USD£1,891GBP
- Report
- June 2022
- 124 Pages
Global
From €4780EUR$5,500USD£4,160GBP
- Report
- May 2022
- 335 Pages
Global
From €4780EUR$5,500USD£4,160GBP
- Report
- August 2021
- 159 Pages
Global
From €4780EUR$5,500USD£4,160GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more